Molecular Pathology in Drug Discovery and Development

Content:
Chapter 1 Molecular Pathology and Drug Development (pages 1–20): Dr. Franz Fogt and Dr. J. Suso Platero
Chapter 2 Molecular Pathology in Oncology Target and Drug Discovery (pages 21–45): Dr. Rolf?P. Ryseck, Dr. Ricardo Attar, Dr. Matthew V. Lorenzi and Dr. Brent A. Rupnow
Chapter 3 Molecular Pathology and Transcriptional Profiling in Early Drug Development (pages 47–84): Dr. Cornelia Liedtke, Dr. Lajos Pusztai and Dr. W. Fraser Symmans
Chapter 4 Molecular Pathology in Nonclinical Safety Assessment (pages 85–110): Dr. Richard A. Westhouse
Chapter 5 Toxicogenomics in Drug Development (pages 111–141): Dr. Wayne R. Buck and Dr. Eric A. G. Blomme
Chapter 6 Molecular Pathology as a Way to Find the Right Dose for a Drug (pages 143–168): Dr. F. Rojo, Dr. A. Rovira, Dr. S. Serrano and Dr. J. Albanell
Chapter 7 Molecular Pathology in Life?Cycle Management in Drug Development (pages 169–193): Dr. Martha Quezado, Dr. Carlos A. Torres?Cabal and Dr. David Berman
Chapter 8 Molecular Pathology and Molecular Therapy (pages 195–220): Dr. Hewei Li
Chapter 9 Molecular Pathology: Immunohistochemistry Assays in Drug Development Performed by a Contract Research Laboratory (pages 221–258): Dr. Frank Lynch and Dr. Steve Bernstein
Chapter 10 Quantification of Molecular Pathology: Colorimetric Immunohistochemistry (pages 259–294): Dr. Raphael Marcelpoil
Chapter 11 Aqua® Technology and Molecular Pathology (pages 295–333): Dr. Mark Gustavson, Dr. Marisa Dolled?Filhart, Dr. Jason Christiansen, Dr. Robert Pinard and Dr. David Rimm